Abstract Body

The presence of ‘defective’ proviruses in HIV-infected patients has been well documented. As these defective proviruses are unable to encode intact viruses, they have been thought of as a silent graveyard of viral sequences. Contrary to this notion, we have recently reported that these ‘defective’ proviruses transcribe novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy including those with HIV-1 RNA levels <50 copies/ml. In the present study, we demonstrate the emergence of these defective proviruses during in vitro infection and their association with HIV-1 protein production in the absence of intact virions.

Single-cell clones were isolated from an H9 T-lymphoid cell line chronically infected with the MN strain of HIV-1. The H9 culture was first separated based on different cell surface characteristics of CD3 and HIV-1 Env gp120 expression by fluorescence-activated cell sorting. Positive wells by HIV-DNA PCR were further cloned by serial dilution at a cell density of 1 cell per well in 96-well plates. The identification of single-cell clones harboring ‘defective’ proviral DNA was confirmed by combining 5’LTR-to-3’LTR single-genome amplification and direct amplicon sequencing of the genomic DNA. RNA transcription in the clones of interest was assessed by RT-PCR of near full-length unspliced HIV-1 RNA species. Cellular expression of HIV-1 proteins was analyzed by western blot and flow cytometry.

Twelve HIV-1 positive individual clones were isolated. Four harbored intact proviruses and expressed Gag p55/p24, RT p66/p51, integrase and Env gp160/gp120 proteins. The remaining eight clones had lethal +1 frameshift mutations in the reverse transcriptase (RT) gene (nucleotide position 3204 of the HXB2), resulting in premature termination of RT translation at Asp 218. Consistent with the DNA and RNA data, western blots revealed the presence of Gag p55/p24 and Env gp160/gp120 proteins and a complete absence of RT p66/p51 and integrase proteins in these eight clones.

In the present study, we demonstrated asynchronous HIV-1 protein production from cells harboring ‘defective’ proviruses that closely resembled the ‘defective’ proviral species found in vivo in patients with HIV-1 infection. The proteins encoded by these ‘zombie’ proviruses may serve as a cause of persistent immune activation during suppressive HIV treatment and may represent a significant hurdle to an HIV-1 cure.